Who is sponsoring NCT04407806?

NCT04407806 is sponsored by Corewell Health East.

What drugs are being tested in NCT04407806?

Interventions in NCT04407806: Continous Pulse oximeter, Intermittent Pulse oximeter.

What condition does NCT04407806 study?

NCT04407806 studies Respiratory Disease, Asthma in Children, Pneumonia in Children, Bronchiolitis Acute.

Is NCT04407806 still recruiting?

NCT04407806 is currently completed. Last updated 10 March 2022.

Are results published for NCT04407806?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2022-03-10 · How we verify

NCT04407806

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Utility of Continuous Pulse Oximetry for Pediatric Patients With Stable Respiratory Illness

Completed NA Results posted Last updated 10 March 2022

What this trial tests

NA trial testing Continous Pulse oximeter in Respiratory Disease in 6 participants. Completed in 2 June 2021.

Timeline

24 December 2020

Primary endpoint
1 May 2021

2 June 2021

Quick facts

Lead sponsor	Corewell Health East
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	6
Start date	24 December 2020
Primary completion	1 May 2021
Estimated completion	2 June 2021
Sites	1 location across United States

Drugs / interventions tested

Continous Pulse oximeter
Intermittent Pulse oximeter

Conditions studied

Respiratory Disease — all drugs for Respiratory Disease →
Asthma in Children — all drugs for Asthma in Children →
Pneumonia in Children — all drugs for Pneumonia in Children →
Bronchiolitis Acute — all drugs for Bronchiolitis Acute →

Sponsor

Corewell Health East — full company profile →

Who can join

Adults 3 Months to 14, any sex, with Respiratory Disease or Asthma in Children. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Length of Stay, Measured in Days Primary · Duration of length of stay, up to 14 days

The start time for measurement of the length of stay will be when the order for either vitals checks or hardwire monitoring is entered in the computer. The end time for measurement of length of stay will be when the discharge order is entered into the computer system.

Group	Value	95% CI
Continuous Pulse Oximetry Monitoring of Oxygen Saturation	1.15	± .20
Intermittent Pulse Oximetry Monitoring of Oxygen Saturation	1.04	± .54

Comfort of Parents: Level of Care Their Child Received in Hospital Secondary · On day of hospital discharge, up to 14 days

Parental rating of care received in hospital, as measured by "Parent Study Questionnaire",using Likert scale, where 5 represents "My child received excellent care" and 1 represents "My child received very poor care". A higher score represents a better outcome.

Group	Value	95% CI
Continuous Pulse Oximetry Monitoring of Oxygen Saturation	5	5 – 5
Intermittent Pulse Oximetry Monitoring of Oxygen Saturation	5	5 – 5

Comfort of Parents: Continuing to Care for Their Child at Home Secondary · On day of hospital discharge, up to 14 days

Comfort level of parents as measured by "Parent Study Questionnaire", using Likert scale where 5 represents "very comfortable with continuing to care for child at home" and 1 represents "very uncomfortable with continuing care for child at home." A higher score represents a better outcome

Group	Value	95% CI
Continuous Pulse Oximetry Monitoring of Oxygen Saturation	5	5 – 5
Intermittent Pulse Oximetry Monitoring of Oxygen Saturation	3	3 – 3

Sponsor's own description

This is a randomized, prospective study to determine if there is a difference in hospital length of stay between patients receiving continuous hardwire cardiorespiratory monitoring and those receiving intermittent vital signs measurements among pediatric patients admitted for uncomplicated respiratory illness.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Respiratory Disease

Currently open trials in the same condition.

NCT06716502 — A New Portable Device for Non-invasive Ventilatory Support · NA · recruiting
NCT06455033 — Manual Diaphragm Release on Stepping Reaction Time in Chronic Obstructive Pulmonary Disease · NA · active not recruiting
NCT06796894 — Symptoms, Respiratory Dysfunction and Frailty Level in Allergic and Eosonophilic Asthmatics · recruiting
NCT06503913 — Cognitive Muscular Therapy for Patients With Long-COVID and Breathing Pattern Disorder · NA · active not recruiting
NCT06569940 — Sleepiz One+ vs. Capnography and Electrocardiography · NA · recruiting

Other Corewell Health East trials

Trials by the same sponsor.

NCT06150599 — Sacral Neuromodulation for Chronic Pelvic Pain · NA · recruiting
NCT06154980 — Randomized Controlled Comparison of Pre-op TLIP vs Intra-op TLIP · NA · withdrawn
NCT06074237 — Improving Vaccine Counseling Skills Among Residents Using Educational Modules and Standardized Patient Encounters · NA · completed
NCT05297305 — Onlay Versus Inlay Humeral Component in Reverse Total Shoulder Arthroplasty · NA · terminated
NCT04074044 — Evaluation of a New Bladder Health Mobile Application in Pregnancy · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04407806 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Corewell Health East
Last refreshed: 10 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04407806.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing